Furthermore, an abundance of cell surface markers, such as CD133 [14,15], CD44 [15,16], CD26 [17,18], CD24 [19], CD166 [20,21], have been reported to be useful in detection and identification of tumor cells, cancer initiating cells and CTCs, in breast, prostate, lung, colon, rectum, and other solid tumors. This evidence concerns the gene PROM1 and cancer.